Site icon Impactiviti

Pharma News 11_2

Barren pipelines abound – the drug drought of pharma.

Schering‘s promising clot drug continues to do well in trials.

Amgen and Roche go another round in court over anemia drugs – this round to Amgen.

Sleep drugs – wildly popular, but how effective? Related news: Sepracor‘s earnings (and a 16% cut in the sales force).

The 2007 drug company layoff tally – sobering.

Takeda‘s experimental cholesterol drug (lapaquistat) takes a hit.

Gila monster saliva diabetes drug looking good in longer-lasting version (Amylin‘s Byetta)

OK, it’s not pharma, but it’s a very cool idea for treating skin cancer – portable, inexpensive light therapy. Fascinating.

Exit mobile version